Today: Today, Opko Health Inc. (OPK) CEO Buys $59,416.00 in Stock

Today, Opko Health Inc. (OPK) CEO Buys $59,416.00 in Stock

Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost purchased 5,600 shares of the stock in a transaction that occurred on Monday, November 28th. The stock was bought at an average cost of $10.61 per share, with a total value of $59,416.00. Following the completion of the transaction, the chief executive officer now directly owns 3,068,951 shares in the company, valued at approximately $32,561,570.11. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Phillip Md Et Al Frost also recently made the following trade(s): On Wednesday, November 23rd, Phillip Md Et Al Frost acquired 4,300 shares of Opko Health stock. The stock was acquired at an average price of $10.09 per share, with a total value of $43,387.00. On Tuesday, November 22nd, Phillip Md Et Al Frost acquired 5,400 shares of Opko Health stock. The stock was acquired at an average price of $10.28 per share, with a total value of $55,512.00. On Monday, November 21st, Phillip Md Et Al Frost acquired 3,600 shares of Opko Health stock. The stock was acquired at an average price of $10.41 per share, with a total value of $37,476.00. On Friday, November 18th, Phillip Md Et Al Frost acquired 1,800 shares of Opko Health stock. The stock was acquired at an average price of $10.38 per share, with a total value of $18,684.00. On Wednesday, November 16th, Phillip Md Et Al Frost acquired 4,300 shares of Opko Health stock. The stock was acquired at an average price of $10.13 per share, with a total value of $43,559.00. On Friday, November 11th, Phillip Md Et Al Frost acquired 14,600 shares of Opko Health stock. The stock was acquired at an average price of $9.46 per share, with a total value of $138,116.00. On Wednesday, November 9th, Phillip Md Et Al Frost acquired 5,400 shares of Opko Health stock. The stock was acquired at an average price of $9.33 per share, with a total value of $50,382.00. On Tuesday, November 8th, Phillip Md Et Al Frost acquired 23,100 shares of Opko Health stock. The stock was acquired at an average price of $9.22 per share, with a total value of $212,982.00. On Wednesday, November 2nd, Phillip Md Et Al Frost acquired 10,000 shares of Opko Health stock. The stock was acquired at an average price of $9.48 per share, with a total value of $94,800.00. On Tuesday, November 1st, Phillip Md Et Al Frost acquired 10,000 shares of Opko Health stock. The stock was acquired at an average price of $9.49 per share, with a total value of $94,900.00.

Opko Health Inc. (NASDAQ:OPK) traded up 0.09% during mid-day trading on Tuesday, hitting $10.63. The company’s stock had a trading volume of 317,659 shares. The company’s 50 day moving average is $9.76 and its 200-day moving average is $9.88. The stock’s market cap is $5.93 billion. Opko Health Inc. has a 52-week low of $7.12 and a 52-week high of $11.85.

Opko Health (NASDAQ:OPK) last posted its quarterly earnings data on Monday, November 7th. The company reported ($0.03) EPS for the quarter, meeting analysts’ consensus estimates of ($0.03). The company earned $298 million during the quarter, compared to analysts’ expectations of $322 million. Opko Health had a negative return on equity of 0.49% and a negative net margin of 0.81%. Opko Health’s revenue for the quarter was up 108.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.25 earnings per share. On average, equities analysts predict that Opko Health Inc. will post ($0.08) EPS for the current fiscal year.

A number of hedge funds have recently bought and sold shares of the stock. LPL Financial LLC raised its stake in Opko Health by 3.9% in the third quarter. LPL Financial LLC now owns 13,374 shares of the company’s stock valued at $142,000 after buying an additional 504 shares in the last quarter. Piedmont Investment Advisors LLC bought a new stake in Opko Health during the third quarter valued at about $622,000. Whalerock Point Partners LLC bought a new stake in Opko Health during the third quarter valued at about $2,100,000. Finally, Price T Rowe Associates Inc. MD raised its stake in Opko Health by 3.1% in the third quarter. Price T Rowe Associates Inc. MD now owns 947,871 shares of the company’s stock valued at $10,038,000 after buying an additional 28,700 shares in the last quarter. Institutional investors own 22.27% of the company’s stock.

OPK has been the subject of several research reports. Jefferies Group reiterated a “hold” rating on shares of Opko Health in a research note on Wednesday, August 17th. JPMorgan Chase & Co. set a $14.00 price target on Opko Health and gave the stock a “buy” rating in a research note on Tuesday, August 9th. Zacks Investment Research upgraded Opko Health from a “sell” rating to a “hold” rating in a research note on Tuesday, October 25th. Oppenheimer Holdings Inc. reiterated a “hold” rating on shares of Opko Health in a research note on Monday, October 10th. Finally, TheStreet downgraded Opko Health from a “hold” rating to a “sell” rating in a research note on Wednesday, November 9th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $13.17.

Opko Health Company Profile

Related posts

Leave a Comment